Trends & Forecasts

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data.

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

The uncertainty surrounding the UK’s future with Europe is having a measurable effect on pharma. But it looks like the end is nowhere in sight.

How will the industry shape up over the next five years?

Healthcare, fake medicines, and the need for new antibiotics – a round-up from the UK East Africa Health Summit.

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Regardless of how Britain leaves the European Union, the global pharma industry must always lobby for positive change.

Why the CVS-Aetna merger could be a transformative event for the pharmaceutical industry.